Pc-Spes (generic name)

treats Prostate cancer
Table of Contents
powered by healthline

Average Ratings

Evidence

DISCLAIMER: These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.

Prostate cancer: Uncontrolled human studies of PC-SPES® have reported improvements in patients with both androgen-dependent and androgen-independent prostate cancer. Overall, these studies found prostate-specific antigen (PSA) levels to fall by greater than 50% in most patients as well as improvements in bone scans and X-rays, reductions in pain scores, and improvements in quality of life. In a 2002 preliminary report (conference abstract) of a comparison between PC-SPES® and diethylstilbestrol (DES) in patients with androgen-independent metastatic prostate cancer, patients treated with PC-SPES® had a greater reduction in PSA levels. However, the later finding that undeclared amounts of DES are present in some PC-SPES® samples clouds these results. Various explanations for the effectiveness of PC-SPES® were initially proposed. Estrogen-like effects were reported prior to 1998. These may be due to herbs with estrogen-like effects or to undeclared estrogenic drugs. The constituent baicalin, a flavone found inScutellaria baicalensis, was found in laboratory experiments to inhibit the enzymes 12-lipoxygenase, 5-alpha-reductase, and aromatase. In addition, PC-SPES® extracts were reported to cause cell death (apoptosis) or to slow the growth of cancer cell lines. The recent finding that different lots of PC-SPES® produced between 1996 and 2001 contained different ingredients from each other has raised questions about whether studies of PC-SPES® can be compared with each other. The discovery of undeclared prescription drug ingredients including the non-steroidal anti-inflammatory drug indomethacin, the synthetic estrogen diethystilbesterol (DES), the estrogen ethinyl estradiol, and the anticoagulant warfarin, make it unclear if these constituents may have caused the observed clinical effects. Because of these complicated circumstances, and the fact that PC-SPES® has never been compared to placebo or standard cancer treatments in a well-reported study, the question of effectiveness remains unclear. Due to known and theoretical safety concerns, samples of PC-SPES® that may be in the possession of patients should not be used.
Grade: C

Tradition

WARNING: DISCLAIMER: The below uses are based on tradition, scientific theories, or limited research. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. There may be other proposed uses that are not listed below.

Dosing

Adult (18 years and older)

Based on known safety concerns associated with PC-SPES®, no dosing regimen is recommended. Samples of PC-SPES® that may be in the possession of patients should not be used.

Children (younger than 18 years)

Based on known safety concerns associated with PC-SPES®, no dosing regimen is recommended. Samples of PC-SPES® that may be in the possession of patients should not be used.

Page: < Back 1 2 3 4 Next >
Licensed from
Top of page
General Drug Tools
General Drug Tools view all tools
Tools for
Healthy Living
Tools for Healthy Living view all tools
Search Tools
Search Tools view all tools
Insurance Plan Tools
Insurance Plan Tools view all tools

What is a reference number?

When you register on this site, you are assigned a reference number. This number contains your profile information and helps UnitedHealthcare identify you when you come back to the site.

If you searched for a plan on this site in a previous session, you might already have a reference number. This number will contain any information you saved about plans and prescription drugs. To use that reference number, click on the "Change or view saved information" link below.

You can retrieve information from previous visits to this site, such as saved drug lists and Plan Selector information.